Evaluation of Cardiology consultations during the COVID-19 Pandemic Period
In this study, we scientifically examined the consultations of the patients being hospitalized from the other departments tothe cardiology department during Coronavirus Disease 2019 (COVID-19) pandemia.Consultations to the cardiology department between 01 April-31 May 2020 and 01 April-31 May 2019 were discussed.Demographic characteristics and reasons of consultations were compared. A different approach was f ollowed in COVID19 patients diagnosed with compared to patients in other clinics.The rate of consulted patients in 2019 year was 14.4% (866/5989). Its rate in 2020 year was found as 18.5% (462/2486) (p:
___
1. Ceraolo C, Giorgi FM. Genomic variance of the 2019‐nCoV coronavirus. Journal of medical virology 2020; 92: 522-528.2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
3. Organization WH. Coronavirus Disease 2019 Situation Reports 2020.
4. Patel A, Jernigan DB, nCo VCDCRT. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019- February 4, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 140-146.
5. Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol 2020.
6. van den Broek MPH, Mohlmann JE, Abeln BGS, et al. Chloroquine-induced QTc prolongation in COVID-19 patients. Neth Heart J 2020; 28: 406- 409.
7. Öztürk F, Karaduman M, Çoldur R, et al. Interpretation of arrhythmogenic effects of COVID-19 disease through ECG. Aging Male 2020: 1-4.
8. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020.
9. Borchert A, Baumgarten L, Dalela D, et al. Managing Urology Consultations During COVID-19 Pandemic: Application of a Structured Care Pathway. Urology 2020; 141: 7- 11.
10. Temiz SA, Dursun R, Daye M, et al. Evaluation Of Dermatology Consultations In The Era Of COVID19. Dermatologic Therapy 2020: e13642.
11. Ji Y, Ma Z, Peppelenbosch MP, et al. Potential association between COVID-19 mortality and health-care resource availability. The Lancet Global Health 2020; 8: e480.
12. Brethauer SA, Poulose BK, Needleman BJ, et al. Redesigning a Department of Surgery during the COVID-19 Pandemic. J Gastrointest Surg 2020; 24: 1852-1859.
13. Sinonquel P, Roelandt P, Demedts I, et al. COVID-19 and gastrointestinal endoscopy: What should be taken into account? Dig Endosc 2020.
14. Puliatti S, Eissa A, Eissa R, et al. COVID-19 and urology: a comprehensive review of the literature. BJU Int 2020; 125: E7-E14.
15. Schirmer CM, Ringer AJ, Arthur AS, et al. Delayed presentation of acute ischemic strokes during the COVID-19 crisis. Journal of NeuroInterventional Surgery 2020; 12: 639-642.
16. Monahan K, Pan M, Opara C, et al. Potential impact of cardiology phone-consultation for patients risk-stratified by the HEART pathway. Clin Exp Emerg Med 2019; 6: 196-203.
17. De Rosa S, Spaccarotella C, Basso C, et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J 2020; 41: 2083-2088.
18. Burgos LM, Diez M, Villalba L, et al. [Impact of the COVID-19 pandemic on heart failure hospitalizations]. Medicina (B Aires) 2020; 80: 315-316.
19. De Filippo O, D'Ascenzo F, Angelini F, et al. Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy. N Engl J Med 2020; 383: 88-89.
20. Vicenzi M, Di Cosola R, Ruscica M, et al. The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients. Eur Respir J 2020; 56.
21. Ushakov AV, Ivanchenko VS, Gagarina AA. Psychological Stress in Pathogenesis of Essential Hypertension. Curr Hypertens Rev 2016; 12: 203- 214.
22. Brack MC, Lienau J, Kuebler WM, et al. Cardiovascular sequelae of pneumonia. Curr Opin Pulm Med 2019; 25: 257-262.
23. Imazio M, Klingel K, Kindermann I, et al. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis? Heart 2020; 106: 1127-1131.
24. Babapoor-Farrokhran S, Gill D, Walker J, et al. Myocardial injury and COVID-19: Possible mechanisms. Life Sci 2020; 253: 117723.
25. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020; 14: 72-73.
26. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020; 56: 105949.
27. Madrid PB, Panchal RG, Warren TK, et al. Evaluation of Ebola Virus Inhibitors for Drug Repurposing. ACS Infect Dis 2015; 1: 317-326.
28. Chorin E, Wadhwani L, Magnani S, et al. QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin. Heart Rhythm 2020.
29. Sapp JL, Alqarawi W, MacIntyre CJ, et al. Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society. Can J Cardiol 2020; 36: 948-951.
30. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol 2020; 75: 2352-2371.
31. Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID19 in China. Clin Res Cardiol 2020; 109: 531-538.
32. Levi M, Thachil J, Iba T, et al. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol 2020; 7: 438-440.
33. [An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19)]. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41: 139-144.
34. Wei L, Lin J, Duan X, et al. Asymptomatic COVID-19 Patients Can Contaminate Their Surroundings: an Environment Sampling Study. Msphere 2020; 5.
35. Yu X, Yang R. COVID-19 transmission through asymptomatic carriers is a challenge to containment. Influenza Other Respir Viruses 2020; 14: 474-475.
36. Vandekerckhove P, Vandekerckhove Y, Tavernier R, et al. Leveraging User Experience to Improve Video Consultations in a Cardiology Practice During the COVID-19 Pandemic: Initial Insights. J Med Internet Res 2020; 22: e19771.
- ISSN: 1301-0883
- Başlangıç: 1996
- Yayıncı: ERBİL KARAMAN
Sayıdaki Diğer Makaleler
Hepatic Portal Venous Gas After Blunt Abdominal Trauma In A Child
Baran Serdar KIZILYILDIZ, Burhan BEGER, Oguzhan OZDEMİR
Elastic Characteristics of The Aorta in Patients with A New Diagnosis of Metabolic Syndrome
Ender Özgün ÇAKMAK, Ali KARAGÖZ, Ugur FİNDİKÇİOĞLU, Emrah ERDOĞAN, Ertuğrul ZENCİRCİ, Fatma Seden ERTEN ÇELİK, Özer SOYLU
Murat ÇAP, Ferhat IŞIK, Önder BİLGE, Bernas ALTINTAŞ, Abdurrahman AKYÜZ, Burhan ARSLAN, Ümit İNCİ, Rojhat ALTINDAĞ, İlyas KAYA, Flora OZKALAYCI, İbrahim Halil TANBOĞA, Kemal GÜNEŞ
Mehmet OBUT, Arife AKAY, Özge YÜCEL ÇELİK, Ayşe KELEŞ, Cantekin İSKENDER, Ali Turhan ÇAĞLAR, ihsan BAĞLI, Ali Emre TAHAOĞLU
Zehra KAYA, Burak Mugdat KARAN, Gokhan GORGİSEN, Necat ALMALİ
Sercan ÖZKAÇMAZ, İlyas Dündar, Leyla Turgut ÇOBAN, Fatma DURMAZ, Iskan ÇALLI, İbrahim İLİK
Buket Mermit ÇİLİNGİR, Aysel SUNNETCİOGLU, Hanifi YİLDİZ, Nuruban Delal BAYKAL, Berrak MERMİT ERÇEK
Sara MASCARETTİ, Carlo MASCİOCCHİ, Giulio MASCARETTİ, Eva FASCETTİ, Angela DALFONSO, Alessandro SERVA, Pietro CİGNİNİ, Michele FICHERA
Faruk KURUHAN, Gülsüm Zuhal KAMİŞ, Abdullah ATLI
Investıgation of The Effect of Multiple Sclerosis on Peripheral Nerves